Evidence map›Paper›PMID 9860989›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Using rare mutations to estimate population divergence times: a maximum likelihood approach.

G Bertorelle, a B Rannala

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 9 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

G BertorelleDepartment of Integrative Biology, University of California, Berkeley, CA 94720-3140, USA. giorgio@mws4.biol.berkeley.edu
a B Rannala
State University of New York · USUniversity of California, Berkeley · US

Funding

VARIATIONS OF HUMAN DNA SEQUENCESP01GM028428 · NIGMS · STANFORD UNIVERSITY · PI CAVALLI-SFORZA, LUIGI L · 1985 to 2004
$6.8M
MODELS OF COMPLEX GENETIC SYSTEMSR01GM040282 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI SLATKIN, MONTGOMERY WILSON · 1988 to 2017
$4.4M
DISEQUILIBRIUM MAPPING OF COMPLEX GENETIC DISEASESR01HG001988 · NHGRI · UNIVERSITY OF CALIFORNIA DAVIS · PI RANNALA, BRUCE · 1999 to 2011
$1.4M
NHGRI NIH HHS HG01988NHGRI NIH HHS R01 HG001988NIGMS NIH HHS GM28424NIGMS NIH HHS GM40282NIGMS NIH HHS P01 GM028428NIGMS NIH HHS R01 GM040282
6 · The paper itself

Abstract

In this paper we propose a method to estimate by maximum likelihood the divergence time between two populations, specifically designed for the analysis of nonrecurrent rare mutations. Given the rapidly growing amount of data, rare disease mutations affecting humans seem the most suitable candidates for this method. The estimator RD, and its conditional version RDc, were derived, assuming that the population dynamics of rare alleles can be described by using a birth-death process approximation and that each mutation arose before the split of a common ancestral population into the two diverging populations. The RD estimator seems more suitable for large sample sizes and few alleles, whose age can be approximated, whereas the RDc estimator appears preferable when this is not the case. When applied to three cystic fibrosis mutations, the estimator RD could not exclude a very recent time of divergence among three Mediterranean populations. On the other hand, the divergence time between these populations and the Danish population was estimated to be, on the average, 4,500 or 15,000 years, assuming or not a selective advantage for cystic fibrosis carriers, respectively. Confidence intervals are large, however, and can probably be reduced only by analyzing more alleles or loci.

Indexed as

Evolution, MolecularGenetic VariationModels, GeneticModels, StatisticalMutationTimeCystic FibrosisDenmarkGenetic Carrier ScreeningHumansItalyLikelihood FunctionsMediterranean RegionPopulation GrowthTurkey

Identifiers

PMID9860989
PMCPMC28063
OpenAlexW2103087073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.